Event-Driven Stocks

RAPID MICRO BIOSYSTEMS, INC.

RPIDNasdaq

Healthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 3 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$33.6M$28.1M$22.5M$17.1M$23.2M$16.1M
Operating income−$47.4M−$49.9M−$56.6M−$63.2M−$47.2M−$30.5M
Net income−$47.1M−$46.9M−$52.5M−$60.8M−$73.5M−$37.1M
Total assets$74.9M$98.2M$143.5M$190.7M$241.2M$70.0M
Total liabilities$41.6M$22.8M$25.5M$26.5M$20.2M$45.2M
Equity$33.2M$75.4M$118.0M$164.2M$221.0M−$127.0M
EPS (diluted)$-1.05$-1.08$-1.22$-1.43$-3.94$-126.11
Shares out.44.7M43.6M43.0M42.5M19.8M358,582

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−141.1%
Net margin
−140.3%
Return on equity
−141.9%
Return on assets
−63.0%
Return on capital (ROCE)
−84.1%
Liabilities / assets
55.6%
Debt / equity
1.25×
Book value / share
$0.74
Revenue growth (YoY)
19.7%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-22.43distress
Accruals / assets
−21.5%clean
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
62
/ 100
Profitability 0Growth 100Catalyst 67Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 3 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026659,8255.2-18.4%
Apr 30, 2026808,8964.2+48.7%
Apr 15, 2026543,8662.9+44.1%
Mar 31, 2026377,5021.4+18.9%
Mar 13, 2026317,4451.4+46.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.